Diagnosis of SARS-CoV-2 infection from breath - a proof-of-concept study.

Authors :: Katende B
Fernández LG
Muhairwe J
Glass TR
Ayakaka I
Labhardt ND
Ruhwald M
de Vos M
Bresser M
Reither K
Source :: IJID regions [IJID Reg] 2022 Dec; Vol. 5, pp. 163-164. Date of Electronic Publication: 2022 Nov 03.
Publication Year :: 2022
Abstract: Bioaerosol capture and analysis is emerging as a non-invasive diagnostic method for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this proof-of-concept study conducted in Lesotho, we evaluated the novel and simple AL2 bioaerosol detection device in comparison to conventional nasopharyngeal sampling methods. We demonstrated for the first time that SARS-CoV-2 can be detected using the AL2 bioaerosol capture device. However, studies with a larger sample size are needed to further evaluate this bioaerosol capture device for the detection of SARS-CoV-2.<br />Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. AL2 Impact and 3M Company provided the bioaerosol capture devices and gave technical advice, but were not involved in data analysis.<br /> (© 2022 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.)